Zydus Cadila gets USFDA nod for low blood pressure drug

Zydus Cadila on Friday said it has received final approval from the US health regulator to market Droxidopa capsules, used to treat low blood pressure. Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Droxidopa capsules in the strength of 100 mg, 200 mg, and 300 mg, Cadila Healthcare said in a regulatory filing.
Read more...

;